Deaths from ovarian cancer fell worldwide between 2002 and 2012 and are predicted to continue to decline in the USA, European Union (EU) and, though to a smaller degree, in Japan by 2020, according to new research published ...
Sep 5, 2016
0
96
Many men with metastatic, hormone-sensitive prostate cancer live longer on continuous androgen-deprivation therapy (also known as hormone therapy) than on intermittent therapy, according to a seventeen-year study led by SWOG, ...
Jun 3, 2012
0
0
Researchers at Karolinska Institutet and Kanazawa University in Japan have made a new discovery that could improve breast cancer treatments. The researchers studied cancer stem cells (CSCs), which can resist chemotherapy ...
Nov 24, 2023
0
74
Exercise helps breast cancer patients with the physical and mental side effects of treatment, a new Loughborough University study has found, and ultimately it may improve disease prognosis.
Mar 25, 2022
0
149
Gender-affirming hormone therapy could influence the way a person's genes are turned on or off, according to a new study.
Mar 1, 2022
0
23
(AP) -- Medicare officials confirmed Thursday that the program will cover the $93,000 price tag for prostate cancer drug Provenge, an innovative therapy that typically gives men suffering from an incurable stage of the disease ...
Jun 30, 2011
0
0
The risk of breast cancer is increased by genetic and lifestyle factors such as the inherited BRCA2 gene, age of having first child, or use of hormone replacement therapy (HRT). New research published in BioMed Central's ...
Nov 28, 2011
0
0
Weight gain is a common complaint of midlife women, with more than two-thirds of midlife US women being over the ideal weight threshold. Aging-related metabolic changes promote weight gain in both sexes, but women face additional ...
Oct 12, 2022
0
36
Researchers at the University of Michigan Comprehensive Cancer Center have identified a type of mutation that develops after breast cancer patients take anti-estrogen therapies. The mutations explain one reason why patients ...
Nov 3, 2013
0
0
Postmenopausal hormone therapy is not associated with increased risk of stroke, provided that it is started early, according to a report from Karolinska Institutet published in the journal PLOS Medicine.
Nov 24, 2017
0
104
